Tissue selectivity is a topic in distribution (pharmacology) and property of some drugs. It refers to when a drug occurs in disproportionate concentrations and/or has disproportionate effects in specific tissues relative to other tissues.[1] An example of such drugs are selective estrogen receptor modulators (SERM) like tamoxifen, which show estrogenic effects in some tissues and antiestrogenic effects in other tissues. Another example is peripherally-selective drugs, which do not cross the blood-brain-barrier into the central nervous system and hence are tissue-selective for the periphery.
References
- ^ Zweten (5 September 1997). Antihypertensive Drugs. CRC Press. p. 345. ISBN 9789057021220.
The term "tissue selectivity" is used for an agent showing varying degrees of potency between tissues, with a preferential action in a given one.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 20 June 2022, at 08:41